Newport Pharmaceuticals International, a Newport Beach-based drug...
- Share via
Newport Pharmaceuticals International, a Newport Beach-based drug maker, has entered into a supply contract with a Japanese company to manufacture a chemical used in an anti-ulcer product marketed throughout the world.
Newport’s subsidiary in Ireland will manufacture the chemical, which is used in famotidine, a drug marketed by Yamanouchi Ireland Company Ltd. Newport’s Irish subsidiary was previously a manufacture of Isoprinosine, the firm’s proprietary drug, which company officials hope will become a treatment for AIDS.
The Berkeley-based Medical Technology Stock Letter recently reported on the agreement, saying that it “will provide some significant revenue, $5 million to $10 million a year.”
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
